Kinesys’ CEO Gerry McGettigan will present on Regulatory & Commercial aspects of Biosimilars at the SMi Conference on 16 November 2015, Renaissance Woodbridge Hotel, Iselin, New Jersey. On 17 November, Gerry and Kinesys’ Product Development Expert Graeme Deuchar will hold an interactive workshop on the development, regulation and commercialisation of Biosimilars.

Kinesys has accumulated a wealth of experience in biosimilars and novel biotechnology products over many years, becoming genuine experts in the field. We have helped developed biosimilar monoclonal antibodies, growth factors and other agents in EU, USA and Asia.

See you there!